UPDATE 1-J&J sales growth disappoints; Co mulling options for diabetes unit

Jan 24 (Reuters) - Johnson & Johnson reported a

smaller-than-expected rise in fourth-quarter sales, hurt by

slowing demand for its medical devices and a stronger dollar.

Read more